Departments of Biology; and.
Pharmacology and Toxicology, Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon; and.
J Cardiovasc Pharmacol. 2020 Feb;75(2):112-122. doi: 10.1097/FJC.0000000000000777.
Myocardial infarction remains a leading cause of morbidity and death. Insufficient delivery of oxygen to the myocardium sets into play a complicated process of repair that involves the temporal recruitment of different immune cells so as to remove debris and necrotic cells expeditiously and to form effective scar tissue. Clearly defined and overlapping phases have been identified in the process, which transitions from an overall proinflammatory to anti-inflammatory phenotype with time. Variations in the strength of the phases as well as in the co-ordination among them have profound consequences. Too strong of an inflammatory phase can result in left ventricular wall thinning and eventual rupture, whereas too strong of an anti-inflammatory phase can lead to cardiac stiffening, arrhythmias, or ventricular aneurisms. In both cases, heart failure is an intermediate consequence with death being the likely outcome. Here, we summarize the role of key immune cells in the repair process of the heart after left ventricular myocardial infarction, along with the associated cytokines and chemokines. A better understanding of the immune response ought to lead hopefully to improved therapies that exploit the natural repair process for mending the infarcted heart.
心肌梗死仍然是发病率和死亡率的主要原因。心肌供氧不足会引发一系列复杂的修复过程,涉及不同免疫细胞的暂时募集,以便迅速清除碎片和坏死细胞,并形成有效的疤痕组织。在这个过程中,已经确定了明确和重叠的阶段,随着时间的推移,从整体的促炎表型向抗炎表型转变。各阶段的强度变化以及它们之间的协调变化都有深远的影响。炎症阶段过强可能导致左心室壁变薄并最终破裂,而抗炎阶段过强可能导致心脏僵硬、心律失常或心室动脉瘤。在这两种情况下,心力衰竭是中间后果,死亡是可能的结果。在这里,我们总结了关键免疫细胞在左心室心肌梗死后心脏修复过程中的作用,以及相关的细胞因子和趋化因子。对免疫反应的更好理解有望导致更好的治疗方法,利用自然修复过程来修复梗死的心脏。